Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Recruiting × belinostat × Clear all

Phase

Phase 3 3 Phase 2 1 Phase 1 1

Status

Completed 14 Terminated 5 Withdrawn 2 Active not recruiting 2 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1 Breast 1

Conditions

Ovarian Neoplasms 1 Breast Neoplasms 1

Interventions

Cyclophosphamide 103 Specimen Handling 98 pembrolizumab 96 Magnetic Resonance Spectroscopy 86 fludarabine 82 Biopsy 72 Injections 42 Bevacizumab 38 venetoclax 37 Radiotherapy 33 Paclitaxel 32 Nivolumab 32 Cetuximab 32 Carboplatin 32 Fluorouracil 31 Cisplatin 31 fludarabine phosphate 29 Gemcitabine 28 Oxaliplatin 25 Immunotherapy, Adoptive 24 Leucovorin 22 Radiation 21 Azacitidine 21 130-nm albumin-bound paclitaxel 20 tislelizumab 19 atezolizumab 19 Cytarabine 19 Ipilimumab 18 Drug Therapy 18 Temozolomide 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04315233 2025-04-22

CHARGE

University of Utah

Phase 1 Recruiting

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡